Cherla A - Search Results

1

Trends in avoidable mortality from cardiovascular diseases in the European Union, 1995-2020: a retrospective secondary data analysis.

Cherla A, Kyriopoulos I, Pearcy P, Tsangalidou Z, Hajrulahovic H, Theodorakis P, Andersson CE, Mehra MR, Mossialos E. Cherla A, et al. Lancet Reg Health Eur. 2024 Sep 27;47:101079. doi: 10.1016/j.lanepe.2024.101079. eCollection 2024 Dec. Lancet Reg Health Eur. 2024. PMID: 39397877 Free PMC article.

2

The 'Netflix plus model': can subscription financing improve access to medicines in low- and middle-income countries?

Cherla A, Howard N, Mossialos E. Cherla A, et al. Health Econ Policy Law. 2021 Apr;16(2):113-123. doi: 10.1017/S1744133120000031. Epub 2020 Mar 3. Health Econ Policy Law. 2021. PMID: 32122423

3

The Coverage in England of US-Approved Cancer Drugs-Reply.

Cherla A, Naci H, Mossialos E. Cherla A, et al. JAMA Intern Med. 2021 Sep 1;181(9):1263-1264. doi: 10.1001/jamainternmed.2021.3339. JAMA Intern Med. 2021. PMID: 34251429 No abstract available.

4

Improving transparency and performance of private hospitals.

Anderson M, Cherla A, Wharton G, Mossialos E. Anderson M, et al. Among authors: cherla a. BMJ. 2020 Feb 14;368:m577. doi: 10.1136/bmj.m577. BMJ. 2020. PMID: 32060033 No abstract available.

5

Rebuilding the broken health contract in Chile.

Crispi F, Cherla A, Vivaldi EA, Mossialos E. Crispi F, et al. Among authors: cherla a. Lancet. 2020 Apr 25;395(10233):1342. doi: 10.1016/S0140-6736(20)30228-2. Lancet. 2020. PMID: 32334699 No abstract available.

6

Cost-effectiveness of cancer drugs: Comparative analysis of the United States and England.

Cherla A, Renwick M, Jha A, Mossialos E. Cherla A, et al. EClinicalMedicine. 2020 Nov 5;29-30:100625. doi: 10.1016/j.eclinm.2020.100625. eCollection 2020 Dec. EClinicalMedicine. 2020. PMID: 33437948 Free PMC article.

7

Post-Marketing Requirements for Cancer Drugs Approved by the European Medicines Agency, 2004-2014.

Cherla A, Mossialos E, Salcher-Konrad M, Kesselheim AS, Naci H. Cherla A, et al. Clin Pharmacol Ther. 2022 Oct;112(4):846-852. doi: 10.1002/cpt.2679. Epub 2022 Jun 23. Clin Pharmacol Ther. 2022. PMID: 35662000 Free PMC article.

8

Faster UK drug approvals by relying on other countries.

Cherla A, Davis C, Mossialos E, Naci H. Cherla A, et al. BMJ. 2023 Apr 5;381:739. doi: 10.1136/bmj.p739. BMJ. 2023. PMID: 37019455 No abstract available.

9

Cost-Effectiveness of Cardiovascular, Obesity, and Diabetes Mellitus Drugs: Comparative Analysis of the United States and England.

Cherla A, Renwick M, Stefanini G, Holmes DR Jr, Mossialos E. Cherla A, et al. J Am Heart Assoc. 2020 Nov 3;9(21):e018281. doi: 10.1161/JAHA.120.018281. Epub 2020 Oct 30. J Am Heart Assoc. 2020. PMID: 33121302 Free PMC article. No abstract available.

10

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval.

Cherla A, Naci H, Kesselheim AS, Gyawali B, Mossialos E. Cherla A, et al. JAMA Intern Med. 2021 Apr 1;181(4):490-498. doi: 10.1001/jamainternmed.2020.8441. JAMA Intern Med. 2021. PMID: 33616607 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters